These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34961494)

  • 21. Does adding lateral pelvic lymph node dissection to neoadjuvant chemotherapy improve outcomes in low rectal cancer?
    Law BZY; Yusuf Z; Ng YE; Aly EH
    Int J Colorectal Dis; 2020 Aug; 35(8):1387-1395. PubMed ID: 32504333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility and safety of lateral pelvic lymph node dissection for elderly patients with middle-low rectal cancer: results of a large multicenter lateral node collaborative group study in China.
    Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q
    Tech Coloproctol; 2023 Aug; 27(8):655-664. PubMed ID: 36515808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer.
    Kroon HM; Hoogervorst LA; Hanna-Rivero N; Traeger L; Dudi-Venkata NN; Bedrikovetski S; Kusters M; Chang GJ; Thomas ML; Sammour T
    Eur J Surg Oncol; 2022 Jul; 48(7):1475-1482. PubMed ID: 35568607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pay attention to the selective lateral pelvic lymph node dissection in mid-low rectal cancer].
    Meng W; Wang Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):258-262. PubMed ID: 28338156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is laparoscopic selective lateral lymph node dissection for locally advanced rectal cancer after neoadjuvant chemoradiotherapy safe?
    Yang X; Gu C; Hu T; Bi L; Wei M; Deng X; Wang Z; Zhou Z
    ANZ J Surg; 2019 Nov; 89(11):E492-E497. PubMed ID: 31566296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncological benefit of lateral pelvic lymph node dissection for rectal cancer treated without preoperative chemoradiotherapy: a multicenter retrospective study using propensity score analysis.
    Ishihara S; Kanemitsu Y; Murono K; Otani K; Yasuda K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Sugihara K; Watanabe T
    Int J Colorectal Dis; 2016 Jul; 31(7):1315-21. PubMed ID: 27240821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
    Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
    Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Impact of Lateral Pelvic Node Dissection on the Survival of Patients in Low Rectal Cancer Subgroups Based on Lymph Node Size.
    Hida K; Nishizaki D; Sumii A; Okamura R; Sakai Y; Konishi T; Akagi T; Yamaguchi T; Akiyoshi T; Fukuda M; Yamamoto S; Arizono S; Uemura M; Hasegawa H; Kawada K; Morita S; Watanabe M;
    Ann Surg Oncol; 2021 Oct; 28(11):6179-6188. PubMed ID: 34255243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
    Gao X; Wang C; Yu Y; Singh D; Yang L; Zhou Z
    World J Surg Oncol; 2020 Nov; 18(1):304. PubMed ID: 33228677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indications and oncological outcomes of selective dissection for clinically suspected lateral lymph node metastasis in patients with rectal cancer based on pretreatment imaging.
    Yang X; Gu C; Hu T; Wei M; Meng W; Wang Z; Deng X; Zhou Z
    Tech Coloproctol; 2021 Apr; 25(4):425-437. PubMed ID: 33585985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.
    Sapci I; Delaney CP; Liska D; Amarnath S; Kalady MF; Steele SR; Gorgun E
    J Gastrointest Surg; 2019 Jul; 23(7):1454-1460. PubMed ID: 31012043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
    Kroon HM; Malakorn S; Dudi-Venkata NN; Bedrikovetski S; Liu J; Kenyon-Smith T; Bednarski BK; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Chang GJ; Sammour T
    Eur J Surg Oncol; 2021 Sep; 47(9):2441-2449. PubMed ID: 34120810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of therapeutic strategies for selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in patients with rectal cancer with clinical suspected lateral lymph node metastasis.
    Liu Y; Bao M; Jiang Y; Li F; Xing W; Yang Z; Liu Q
    Front Oncol; 2023; 13():1271463. PubMed ID: 37886180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors and histological effects of preoperative chemoradiotherapy for rectal cancer and control of lateral lymph node metastasis.
    Miyakita H; Chan LF; Okada K; Kayano H; Mori M; Sadahiro S; Yamamoto S
    BMC Gastroenterol; 2022 Jul; 22(1):334. PubMed ID: 35804299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term clinical outcomes of total mesorectal excision and selective lateral pelvic lymph node dissection for advanced low rectal cancer: a comparative study of a robotic versus laparoscopic approach.
    Song SH; Choi GS; Kim HJ; Park JS; Park SY; Lee SM; Choi JA; Seok HA
    Tech Coloproctol; 2021 Apr; 25(4):413-423. PubMed ID: 33594627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of treatment strategies based on preoperative imaging features and local recurrence areas for locally advanced lower rectal cancer after lateral pelvic lymph node dissection.
    Xu Z; Bao M; Cai Q; Wang Q; Xing W; Liu Q
    Front Oncol; 2023; 13():1272808. PubMed ID: 38375201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thirty years' changes of the strategy of lateral lymph node dissection in low rectal cancer: treatment experience and prognostic analysis of 289 cases in one single center].
    Tang JQ; Li HY; Liu T; Zhang JL; Zuo S; Sun L; Wu YC; Jiang Y; Chen GW; Wu T; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):889-896. PubMed ID: 34674464
    [No Abstract]   [Full Text] [Related]  

  • 38. Lateral lymph node involvement presents another challenge in rectum cancer in the age of neoadjuvant chemoradiotherapy + total mesorectal excision: an evaluation of survival outcomes.
    Özdemir Ü; Gündoğdu E; Yakar M; Canaz F; Ulaş M; Özer İ
    Langenbecks Arch Surg; 2023 Sep; 408(1):356. PubMed ID: 37702958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative lateral lymph node features and impact on local recurrence after neoadjuvant chemoradiotherapy and total mesorectal excision for locally advanced rectal cancer: results from a multicentre international cohort study.
    Achilli P; Ferrari D; Calini G; Bertoglio CL; Magistro C; Origi M; Carnevali P; Alampi BD; Giusti I; Ferrari G; Calafiore E; Spinelli A; Grass F; Deslarzes P; Hahnloser D; Abdalla S; Larson DW
    Colorectal Dis; 2024 Mar; 26(3):466-475. PubMed ID: 38243617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns.
    Yamamoto T; Kawada K; Hida K; Ganeko R; Inamoto S; Yoshitomi M; Watanabe T; Sakai Y
    Int J Clin Oncol; 2019 Jun; 24(6):677-685. PubMed ID: 30721379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.